Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Testing of Device from Other Lot/Batch Retained by Manufacturer	NCIT_C139448	[The investigation employed relevant empirical testing of the device of another lot or batch than that of the suspected device in the reported adverse event in order to support the identification of possible causes for the adverse event. This includes devices without a lot/batch designation. Testing was performed using the device retained by the manufacturer (i.e. was not shipped). Relevant testing would typically be based on test methods used for evaluating safety and performance as described in the latest relevant standards.]
Cutaneous Melanoma pTX TNM Finding v6	NCIT_C48839	[Cutaneous melanoma in which the primary tumor cannot be assessed. (from AJCC 6th Ed.)]
Cutaneous Melanoma Pathologic Primary Tumor TNM Finding v6	NCIT_C48894	[A pathologic finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v6 classification system as they pertain to staging of the primary tumor. TNM pathologic primary tumor findings are based on clinical findings supplemented by histopathologic examination of one or more tissue specimens acquired during surgery.]
Testing of Device from Other Lot/Batch Returned from User	NCIT_C139449	[The investigation employed relevant empirical testing of the device of another lot or batch than that of the suspected device in the reported adverse event in order to support the identification of possible causes for the adverse event. This includes devices without a lot/batch designation. The device was returned from the user. Relevant testing would typically be based on test methods used for evaluating safety and performance as described in the technical file. Relevant testing would typically be based on test methods used for evaluating safety and performance as described in the latest relevant standards.]
Fellowship for the Interpretation of Genomes	NCIT_C48833	[A non-profit organization specializing in bioinformatics tool development and comparative genomics research.]
Breast Cancer pN3b TNM Finding v8	NCIT_C139443	[Breast cancer with pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b. (from AJCC 8th Ed.)]
Breast Cancer pN3 TNM Finding v8	NCIT_C139441	[Breast cancer with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. (from AJCC 8th Ed.)]
Correlation	NCIT_C48834	[The degree to which two or more quantities or events are linearly associated, a statistical relation between two or more variables such that systematic changes in the value of one variable are accompanied by systematic changes in the others.]
Breast Cancer pN3c TNM Finding v8	NCIT_C139444	[Breast cancer with metastases in ipsilateral supraclavicular lymph nodes. (from AJCC 8th Ed.)]
Role	NCIT_C48835	[The usual or expected function of something; the part something plays in an action or event.]
Breast Cancer Anatomic Stage	NCIT_C139445	[Breast cancer staging used in global regions where biomarker tests are not routinely available.]
78 kDa Glucose-Regulated Protein	NCIT_C48836	[78 kDa glucose-regulated protein (654 aa, ~72kDa) is encoded by HSPA5 gene. The protein is intracellularly localized in the endoplasmic reticulum lumen, and plays a role in the assembly of multimeric protein complexes inside the organelle. In addition, the protein is thought to function as a pro-survival protein, or an inhibitor of apoptosis.]
Breast Cancer Prognostic Stage	NCIT_C139446	[Breast cancer staging used in countries in which biomarker tests are routinely performed.]
Cutaneous Melanoma pT0 TNM Finding v6 and v7	NCIT_C48840	[Cutaneous melanoma with no evidence of primary tumor. (from AJCC 6th and 7th Eds.)]
Cutaneous Melanoma pTis TNM Finding v6 and v7	NCIT_C48841	[Cutaneous melanoma in situ. (from AJCC 6th and 7th Eds.)]
Breast Cancer pN2b TNM Finding v8	NCIT_C139440	[Breast cancer with metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes. (from AJCC 8th Ed.)]
Breast Cancer pN2 TNM Finding v8	NCIT_C139438	[Breast cancer with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)]
Cutaneous Melanoma pT1 TNM Finding v6	NCIT_C48842	[Cutaneous melanoma 1.0mm or less in thickness, with or without ulceration. (from AJCC 6th Ed.)]
Breast Cancer Pathologic Regional Lymph Nodes TNM Finding v8	NCIT_C139428	[A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.]
Cutaneous Melanoma pT1a TNM Finding v6	NCIT_C48843	[Cutaneous melanoma 1.0mm or less in thickness and Clark level II or III, with no ulceration. (from AJCC 6th Ed.)]